Xcelience Adds Minipress

Xcelience has expanded its formulation development and manufacturing capabilities with the addition of a Piccola B10 Minipress. The 10-station tabletop rotary tablet press enables clients to make an early assessment of how the developed process and formula will perform in production, in order to shorten development time. The press can also produce small batch sizes in the experimental area while obtaining the necessary processing parameters.

The Piccola B10 Minipress is equipped with a data acquisition and analysis system and, according to the company, provides clients with detailed analysis such as compaction profiles, strain rate studies, single compaction event investigation and statistical analysis of each production run.

“Adding a bench scale tablet press in the experimental area is consistent with our strategy of providing equipment appropriately scaled to the needs of our clients,” said Paul Skultety, Ph.D., director of Pharmaceutical Development Services. “The Piccola scales nicely to our existing Fette 1200i instrumented press in our cGMP manufacturing area, and helps clients build towards improved manufacturing outcomes in a manner consistent with the FDA’s Quality by Design initiative.”